The Alzheimer’s Impact Movement (AIM) engages with corporate partners on various projects including advocate training, health economics, legal issues surrounding a diagnosis and public opinion polling.

No contribution from any entity impacts AIM decision-making, nor our positions on issues related to people living with Alzheimer’s, other dementia and their families. Total contributions from the pharmaceutical industry make up less than 2% of AIM’s total contributed revenue.

Become a Corporate Champion Today

We recognize our current corporate partners for their generous support.

GOLD ($50,000)

SILVER ($25,000)

BRONZE ($10,000)